Stronger Warnings Advised on Asthma Drug

Heather said: "Federal regulatory advisers have recommended strengthening safety warnings on GlaxoSmithKline?s asthma drug Serevent amid reports of deaths in children taking the treatment. [url=http://www.nytimes.com/2007/11/29/business/29drug.html?ex=1353992400&en=84b6f9658827141b&ei=5088&partner=rssnyt&emc=rss]More...[/url]"